首页> 外文期刊>The Lancet >Authors' reply
【24h】

Authors' reply

机译:作者的回复

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Andreas Voss and colleagues have alluded to the fact that 16SrRNA sequencing in the early 2000s allowed Elizabethkingia to be placed separately from the genus of Chryseobacterium. Next-generation sequencing has facilitated a higher level of differentiation between two very distinct species of Elizabethkingia, namely Elizabethkingia meningoseptica and Elizabethkingia anophelis.1,2 Our analyses identifying the intensive-care unit outbreak strain as E anophelis is not just a reclassification of an old species as Voss and colleagues suggest. £ anophelis is an entirely separate species with infection potential. £ anophelis is presently understudied but should not be considered irrelevant in the clinical setting. Our sequencing data suggest the presence of a substantial number of virulence determinants, and studies to assess £ anophelis' virulence potential in animal are in progress.
机译:andreas voss和同事们已经提到了2000年代初的16srrna测序允许伊丽莎白岛与蛹虫杆菌属分开放置。 下一代测序促进了两种非常独特的伊丽莎白紫红色的种类差异较高的差异,即伊丽莎白别善脑膜细胞和伊丽莎白别善血症类嗜酸皮肤.1,2我们的分析鉴定了eNophelis的重症监护单元爆发菌株,这不仅仅是一个旧的重新分类 voss和同事的物种建议。 £anophelis是一种完全独立的物种,具有感染潜力。 目前将解读£anophelis,但在临床环境中不应被视为无关紧要。 我们的测序数据表明存在大量的毒力决定簇,以及评估动物中血管毒力潜力的研究正在进行中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号